To examine the potential tumorcidial effects of GNLY, HIS and control (standard NOD/SCID mice) were challenged with subcutaneous injection of 5×106 CL1-5 (metastatic lung cancer cells) and HT29 (colorectal cancer cells) tumor cells. The gene discussed is GNLY; the disease is lung carcinoma.